Respiri (KMLXF) Stock Price, News & Analysis

Company Overview

Respiri (OTCMKTS:KMLXF) is a digital health company focused on empowering patients with respiratory conditions through connected monitoring solutions. The company’s flagship offering, wheezo®, is a compact sensor that attaches directly to a patient’s inhaler, capturing airflow data and wheezing patterns during use. This device syncs with a companion smartphone application, enabling users and healthcare providers to track treatment adherence, symptom trends and early signs of exacerbation in real time.

In addition to its inhaler‐based sensor, Respiri operates a cloud‐hosted analytics platform that aggregates patient data for remote monitoring and telehealth integration. The platform generates reports and alerts that clinicians can use to adjust treatment plans, enhance preventive care and reduce the risk of hospital visits. Designed for patients with asthma, chronic obstructive pulmonary disease (COPD) and other respiratory conditions, Respiri’s solution aims to bridge gaps in disease management by offering objective, continuous measurements outside the clinic.

Founded in Australia and headquartered in Melbourne, Respiri has secured CE marking for wheezo® and launched commercial operations across Australia, New Zealand and selected European markets. The company continues to pursue regulatory clearances and strategic partnerships to expand its geographic footprint, with a focus on strengthening ties with healthcare providers, pharmacies and research institutions. Through ongoing product development and clinical collaborations, Respiri seeks to establish itself as a leader in home‐based respiratory monitoring and digital therapeutics.

Key Stats

• Today's Range: $0.06 to $0.06
• 50-Day Range: $0.06 to $0.06
• 52-Week Range: $0.04 to $0.05
• Volume: N/A
• Average Volume: 6,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KMLXF Stock Analysis - Frequently Asked Questions

How have KMLXF shares performed this year?

Respiri's stock was trading at $0.0581 at the beginning of 2025. Since then, KMLXF shares have increased by 0.0% and is now trading at $0.0581.

How do I buy shares of Respiri?

Shares of KMLXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 9/16/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:KMLXF
• CIK: N/A
• Web: www.respiri.co
• Phone: 61 3 9653 9160
• Fax: 61 -0-3 9602 3606
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.07 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.07